A step closer to a cure: Gilead seeks FDA OK of oral attack on hepatitis C
February 10, 2014 at 16:43 PM EST
Gilead Sciences Inc. asked U.S. regulators Monday to approve what could be the first oral treatment for most hepatitis C patients...
